diallyl disulfide has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, G; Li, L; Mu, H; Sun, J; Tan, H; Yan, H; Yang, N; Yang, X; Yi, L; Yu, J | 1 |
| Ji, XX; Lin, M; Ma, YH; Su, Q; Tan, H; Tang, Y; Wen, L; Yi, L | 1 |
2 other study(ies) available for diallyl disulfide and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Diallyl disulfide down-regulates calreticulin and promotes C/EBPα expression in differentiation of human leukaemia cells.
Topics: 3' Untranslated Regions; Adolescent; Adult; Aged; Aged, 80 and over; Allyl Compounds; Animals; Antineoplastic Agents, Phytogenic; Calreticulin; CCAAT-Enhancer-Binding Proteins; Cell Differentiation; Disulfides; Down-Regulation; Female; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Mice, SCID; Middle Aged; Xenograft Model Antitumor Assays; Young Adult | 2019 |
Role of Ras-related C3 botulinum toxin substrate 2 (Rac2), NADPH oxidase and reactive oxygen species in diallyl disulphide-induced apoptosis of human leukaemia HL-60 cells.
Topics: Allyl Compounds; Apoptosis; Caspase 3; Cell Line, Tumor; Disulfides; DNA Fragmentation; Flow Cytometry; HL-60 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Myeloid, Acute; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-myc; rac GTP-Binding Proteins; RAC2 GTP-Binding Protein; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Transcription Factor AP-1; Up-Regulation | 2010 |